xanomeline has been researched along with Mental Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodick, NC; Bymaster, FP; Cutler, NR; Gauthier, SG; Hurley, DJ; Levey, AI; Offen, WW; Paul, SM; Potter, WZ; Rasmussen, K; Satlin, A; Shannon, HE; Tollefson, GD | 1 |
1 trial(s) available for xanomeline and Mental Disorders
| Article | Year |
|---|---|
Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease.
Topics: Alzheimer Disease; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Mental Disorders; Middle Aged; Muscarinic Agonists; Placebos; Pyridines; Thiadiazoles | 1997 |